Arizona State Retirement System’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Arizona State Retirement System’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-29,414	Closed	-$124K	–	2278
2023 Q1	$124K	Buy	29,414 +3,593	+14%	+$18.6K	﹤0.01%	2074
2022 Q4	$155K	Buy	+25,821	New	+$141K	﹤0.01%	2001

Other funds holding CTIC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Arizona State Retirement System's CTIC Position: Q2 2023 in Review

Arizona State Retirement System sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 29,414 shares — an estimated $124K sold.

Arizona State Retirement System first reported a position in CTIC in Q4 2022 and held it in 2 quarters. The position peaked at $155K in Q4 2022. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.

Arizona State Retirement System reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
Arizona State Retirement System sold 29,414 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $124K.
Arizona State Retirement System first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q4 2022 and held it in 2 quarters.
Arizona State Retirement System's CTI BioPharma Corp. (DE) Common Stock position peaked at $155K in Q4 2022.
2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.

Based on Arizona State Retirement System's 13F filing for Q2 2023, filed 1 Aug 2023.